NasdaqCM:CELCBiotechs
Is Celcuity’s New Oncology Commercial Leader Appointment Reshaping the Investment Case for CELC?
Celcuity Inc. recently appointed Charles (Chip) R. Romp, a veteran oncology commercial leader and current CEO of Secura Bio, to its Board of Directors, adding deep pharmaceutical sales and commercialization expertise to its governance team.
Romp’s experience building commercial franchises at Seagen and Genentech across key oncology brands could meaningfully shape how Celcuity prepares for potential future product launches and market positioning.
We’ll now examine how Romp’s extensive...